Foresite Capital Management III’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Foresite Capital Management III’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-454,656	Closed	-$2.11M	–	18
2019 Q2	$2.11M	Sell	454,656 -175,000	-28%	-$815K	0.69%	18
2019 Q1	$3.34M	Hold	629,656	–	–	0.87%	18
2018 Q4	$2.33M	Hold	629,656	–	–	0.77%	19
2018 Q3	$1.76M	Buy	629,656 +610,156	+3,129%	+$1.71M	0.39%	23
2018 Q2	$58K	Sell	19,500 -130,504	-87%	-$309K	0.01%	24
2018 Q1	$338K	Buy	+150,004	New	+$351K	0.07%	23
2016 Q4	–	Sell	-47,158	Closed	-$127K	–	24
2016 Q3	$127K	Sell	47,158 -23,019	-33%	-$58.5K	0.06%	17
2016 Q2	$166K	Sell	70,177 -137,321	-66%	-$379K	0.11%	18
2016 Q1	$670K	Buy	+207,498	New	+$767K	0.52%	21

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Foresite Capital Management III's BDSI Position: Q3 2019 in Review

Foresite Capital Management III sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2019, closing a stake of 454,656 shares — an estimated $2.11M sold.

Foresite Capital Management III first reported a position in BDSI in Q1 2016 and held it in 9 quarters. The position peaked at $3.34M in Q1 2019. 119 funds tracked by Wall St. Rank hold BDSI as of Q3 2019.

Foresite Capital Management III reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2019 after selling out during the quarter.
Foresite Capital Management III sold 454,656 BioDelivery Sciences International, Inc. shares in Q3 2019, an estimated $2.11M.
Foresite Capital Management III first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 9 quarters.
Foresite Capital Management III's BioDelivery Sciences International, Inc. position peaked at $3.34M in Q1 2019.
119 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2019.

Based on Foresite Capital Management III's 13F filing for Q3 2019, filed 13 Nov 2019.